Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

Eiken Chemical Provides Space To Otsuka’s Shanghai Research Institute

This article was originally published in PharmAsia News

Executive Summary

Tokyo-based Eiken Chemical is providing space inside its China subsidiary Eiken Biotechnology Shanghai to Ostuka Pharmaceutical. The space is being used as a basic medical research facility for Otsuka. The two companies have been collaborating in clinical diagnostic business. Established in 2004, Eiken's Shanghai subsidiary manufactures a fecal occult blood testing agent that is marketed in overseas markets and urine testing paper marketed in Japan. (Click here for more - Japanese language

Table

View full table

Tags:
Latest Headlines

The UK’s Cancer Vaccine Partnership With BioNTech Is Another First – But Can It Deliver?

NASDAQ Is Nice But Home Provides Comfort For Europe’s Biotechs

Amgen Planning Pivotal Obesity Program For MariTide

Novartis Looks To Maintain A Lead In Radiopharmaceuticals With Mariana Takeout

See All
UsernamePublicRestriction

Register

SC070761

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By